Skip to main content
. 2013 Feb 13;8(2):e56169. doi: 10.1371/journal.pone.0056169

Figure 3. SGLT1 overexpression in cervical tumors.

Figure 3

A) MAP17 expression in Hela cells increases glucose uptake that is blocked by the SGLT inhibitor phloridzine. B) Western blot analysis was performed for SGLT1 in Hela cells expressing MAP17 or vector alone (V). C) Representative images are shown of SGLT1 immunostaining of different cervical tumor subtypes. D) A graph is shown representing the percentage of cervical tumors with different SGLT1 levels. E) A graph is shown representing the percentage of SGLT1-positive tumors by tumor subtype.